Advanced glycation end products promote differentiation of CD4+ T helper cells toward pro-inflammatory response

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 34, Issue 1, 2014, Pages 10-17

  Han, Xiao Qun ^a   Gong, Zuo Jiong ^a   Xu, San Qing ^b   Li, Xun ^a   Wang, Li Kun ^a   Wu, Shi Min ^c   Wu, Jian Hong ^c   Yang, Hua Fen ^c  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c Wuhan Medical Treatment Center   (China)

Author keywords

advanced glycation end products; CD4+ T cell subsets; diabetes; pro inflammatory response

Indexed keywords

9-DEOXY-DELTA-9-PROSTAGLANDIN D2; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; BOVINE SERUM ALBUMIN; DRUG DERIVATIVE; GAMMA INTERFERON; GLUCOSE; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 17; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN D2; PROSTAGLANDIN J2;

ADULT; ANIMAL; ARTICLE; CATTLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL DIFFERENTIATION; DRUG EFFECT; DRUG POTENTIATION; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TH1 CELL; TH17 CELL; WESTERN BLOTTING;

ADULT; ANIMALS; BLOTTING, WESTERN; CATTLE; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEK293 CELLS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; PPAR GAMMA; PROSTAGLANDIN D2; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SERUM ALBUMIN, BOVINE; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS;

EID: 84894079414     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-014-1224-1     Document Type: Article

References (30)

1. van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev, 2011,91(1):79-118
2. Ginter E, Simko V. Type 2 diabetes mellitus, pandemic in 21st century. Adv Exp Med Biol, 2012,771:42-50
3. Nikolajczyk BS, Jagannathan-Bogdan M, Shin H, et al. State of the union between metabolism and the immune system in type 2 diabetes. Genes Immun, 2011,12(4): 239-250
4. Culina S, Brezar V, Mallone R. Insulin and type 1 diabetes: immune connections. Eur J Endocrinol, 2013,168(2): R19-R31
5. Zhu J, Paul WE. Heterogeneity and plasticity of T helper cells. Cell Res, 2010,20(1):4-12
6. Hirota K, Martin B, Veldhoen M. Development, regulation and functional capacities of Th17 cells. Semin Immunopathol, 2010,32(1):3-16
7. Ohkura N, Kitagawa Y, Sakaguchi S. Development and maintenance of regulatory T cells. Immunity, 2013 38(3):414-423
8. Zeng C, Shi X, Zhang B, et al. The imbalance of Th17/Th1/Treg in patients with type 2 diabetes: relationship with metabolic factors and complications. J Mol Med, 2012,2(90):175-186
9. Shao S, He F, Yang Y, et al. Th17 cells in type 1 diabetes. Cell Immun, 2012,1(280):16-21
10. Geerlings SE, Hoepelman AM. Immune dysfunction in patients with mellitus (DM). FEMS Immunol Med Microbiol, 1999,26(3-4):259-265
11. Thomas MC. Advanced glycation end products. Contrib Nephrol, 2011,170:66-74
12. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes, 2005,54(6):1615-1625
13. Lin J, Tang Y, Kang Q, et al. Curcumin inhibits gene expression of receptor for advanced glycation end-products (RAGE) in hepatic stellate cells in vitro by elevating PPARγ activity and attenuating oxidative stress. Br J Pharmacol, 2012,166(8): 2212-2227
14. Miele C, Riboulet A, Maitan MA, et al. Human glycated albumin affects glucose metabolism in L6 skeletal muscle cells by impairing insulin-induced insulin receptor substrate (IRS) signaling through protein kinase C alpha-mediated mechanism. J Biol Chem, 2003,278(48): 47 376-47 287
15. Fraley S, Feng Y, Krishnamurthy R, et al. A distinctive role for focal adhesion proteins in three-dimensional cell motility. Nat Cell Biol, 2010,12(6):598-604
16. Franke S, Rüster C, Pester J, et al. Advanced glycation end products affect growth and function of osteoblasts. Clin Exp Rheumatol, 2011,29(4):650-660
17. Sato T, Wu X, Shimogaito N, et al. Effects of high-AGE beverage on RAGE and VEGF expressions in the liver and kidneys. Eur J Nutr, 2009,48(1):6-11
18. Poulsen L, Siersbaek M, Mandrup S. PPARs: fatty acid sensors controlling metabolism. Semin Cell Dev Biol, 2012,23(6):631-639
19. Ahmadian M, Suh JM, Hah N, et al. PPARγ signaling and metabolism: the good, the bad and the future. Nat Med, 2013,19(5):557-566
20. Mahali SK, Manna SK. Beta-D-glucoside protects against advanced glycation end products (AGEs)-mediated diabetic responses by suppressing ERK and inducing PPAR gamma DNA binding. Biochem Pharmacol, 2012,84(12): 1681-1690
21. Wang SH, Guo YJ, Yuan Y, et al. PPARγ-mediated advanced glycation end products regulate neural stem cell proliferation but not neural differentiation through the BDNF-CREB pathway. Toxicol Lett, 2011,206(3): 339-346
22. Matsui T, Yamagishi S, Takeuchi M, et al. Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation. Biochem Biophys Res Commun, 2010,398(2):326-330
23. Wållberg M, Cooke A. Immune mechanisms in type 1 diabetes. Trends Immunol, 2013,12(34):583-591
24. Yamane H, Paul WE. Early signaling events that underlie fate decisions of naive CD4(+) T cells toward distinct T-helper cell subsets. Immunol Rev, 2013,252(1):12-23
25. Kitagishi Y, Kobayashi M, Yamashina Y, et al. Elucidating the regulation of T cell subsets (review). Int J Mol Med, 2012,30(6):1255-1260
26. Wambre E, James EA, Kwok WW. Characterization of CD4+ T cell subsets in allergy. Curr Opin Immunol, 2012,24(6):700-706
27. Serr I, Weigmann B, Franke RK, et al. Treg vaccination in autoimmune type 1 diabetes. BioDrugs, 2013 [Epub ahead of print]
28. Zong H, Ward M, Stitt AW. AGEs, RAGE, and diabetic retinopathy. Curr Diab Rep, 2011,11(4):244-252
29. Cipolletta D, Feuerer M, Li A, et al. PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature, 2012,486(7404):549-553
30. Berger H, Végran F, Chikh M, et al. SOCS3 transactivation by PPARγ prevents IL-17-driven cancer growth. Cancer Res, 2013,73(12):3578-3590